The results include the notice of the Minister of Health, effective 1st of January 2022. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations for drugs with no reimbursed equivalents. With our PREDECIZER approach, we analyzed

The results include the notice of the Minister of Health, effective 1st of November 2021. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations for drugs with no reimbursed equivalents. With our PREDECIZER approach, we analyzed

Reimbursement decisions in Poland. MoH reimbursement in September 202

The results include the notice of the Minister of Health, effective 1st of July 2021. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations for drugs with no reimbursed equivalents. With our PREDECIZER approach, we analyzed

The results include the notice of the Minister of Health, effective 1st of May 2021. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations for drugs with no reimbursed equivalents. With our PREDECIZER approach, we analyzed

The results include the notice of the Minister of Health, effective 1st of March 2021. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations for drugs with no reimbursed equivalents. With our PREDECIZER approach, we analyzed

The results include the notice of the Minister of Health, effective 1st of January 2021. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations for drugs with no reimbursed equivalents. With our PREDECIZER approach, we analyzed

The results include the notice of the Minister of Health, effective 1st of November 2020. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations for drugs with no reimbursed equivalents. With our PREDECIZER approach, we analyzed the

The results include the notice of the Minister of Health, effective 1st of September 2020. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations for drugs with no reimbursed equivalents. With our PREDECIZER approach, we analyzed

The results include the notice of the Minister of Health of 18 February 2020, effective 1st of March 2020. We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations for drugs with no reimbursed equivalents. With our PREDECIZER